Home
About Us
Science
Newsroom
Careers
Contact
中文
EN
About Us
Science
Newsroom
Careers
Contact
中文
EN
Media Coverage
Luhan Yang | With the completion of Pre-B round financing and the first product entering clinical stage, what will be the next step for Qihan Biotech?
November 2023
Yiyaoguanlan
The Bloomberg 50
November 2017
Bloomberg
Luhan Yang, Qihan Biotech: In the name of science, reverence for the greatness of life
May 2021
Sequoia
2023
Luhan Yang | With the completion of Pre-B round financing and the first product entering clinical stage, what will be the next step for Qihan Biotech?
November 2023
Yiyaoguanlan
2022
Luhan Yang, Qihan Biotech: Curing patients by cellular gene editing and organ grafting therapies
May 2022
VBDATA.CN
2021
Luhan Yang, Qihan Biotech: A young CEO with a protagonist halo
December 2021
HaloValley
Luhan Yang, Qihan Biotech: Founded Qihan in China and dedicated to popularizing cell and organ therapies through gene editing
June 2021
Bioworld
Luhan Yang, Qihan Biotech: In the name of science, reverence for the greatness of life
May 2021
Sequoia
First GM pigs for allergies. Could xenotransplants be next?
April 2021
Nature Biotechnology
Qihan raises $67M to advance cell and organ therapies in China
March 2021
Bioworld
Gene Editing for Transplants and Cell Therapy: Luhan Yang on the Long Run
January 2021
Timmerman Report
2020
Guide RNAs: it’s good to be choosy
November 2020
Nature Methods
7TH China Healthcare Summit——Blue Ribbon Panel: China Biotech CEO Panel
November 2020
7TH China Healthcare Summit
Luhan Yang: the Pioneer of Multi-gene Editing and Immune Privilege
October 2020
vcbeat
Luhan Yang : To do something "bigger than myself"
September 2020
Huanqiu
"Pig 3.0", Which is Expected to be Used in Clinical Xenotransplantation was Born
September 2020
Xinhua News
Luhan Yang| 2020 40 under 40 in Health| Fortune
September 2020
Fortune
2019
Eyeing organs for human transplants, companies unveil the most extensively gene-edited pigs yet
December 2019
Science
Qihan Bio Inc. (Hangzhou, China) raised $25.5M series A+ round after raising a $7.8 million Series A round in 2018
September 2019
Biocentury
Your New Heart Could Be Made in China
August 2019
Bloomberg
2018
Chinese xenotransplantation company Qihan grabs $7.8M series A
July 2018
Biocentury
Using Medicine and Science to Improve the Quality of Life
May 2018
The New York Times
TED Talk: How to create a world where no one dies waiting for a transplant
April 2018
TED
2017
The Bloomberg 50
November 2017
Bloomberg
What Gene-Altering for Pigs and Ants Might Mean for Humans
August 2017
The Wall Street Journal
Gene Editing Spurs Hope for Transplanting Pig Organs Into Humans
August 2017
The New York Times
A startup cofounded by a 31-year-old just got a step closer to transplanting pig organs into humans
August 2017
Business Insider
Scientists are Getting Closer To Using Pig Organs For Human Transplants
August 2017
TIME
Meet the 2017 Class of Young Global Leaders
March 2017
World Economic Forum
2016
Genetically Modified Pigs Could Ease Organ Shortage
December 2016
The Wall Street Journal
2015
Gene-editing method revives hopes for transplanting pig organs into people
October 2015
Science
2014
Gene-editing record smashed in pigs
January 2014
Nature
30 UNDER 30: SCIENCE & HEALTHCARE
January 2014
Forbes
